Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): geographic region subgroups in EMPOWER-Lung 1
dc.authorid | Saadettin Kılıçkap / 0000-0003-1637-7390 | en_US |
dc.authorscopusid | Saadettin Kılıçkap / 8665552100 | en_US |
dc.authorwosid | Saadettin Kılıçkap / AAP-3732-2021 | en_US |
dc.contributor.author | Ho, Gwo Fuang | |
dc.contributor.author | Sezer, Ahmet | |
dc.contributor.author | Kılıçkap, Saadettin | |
dc.contributor.author | Bondarenko, Igor | |
dc.contributor.author | Özgüroğlu, Mustafa | |
dc.contributor.author | Gogishvili, Miranda | |
dc.date.accessioned | 2023-05-23T08:28:02Z | |
dc.date.available | 2023-05-23T08:28:02Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | (Özet Yok / Not Abstract Avaliable) | en_US |
dc.identifier.citation | Ho, G. F., Sezer, A., Kilickap, S., Gumus, M., Bondarenko, I., Ozguroglu, M., ... & Quek, R. G. (2022). 334P Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): Geographic region subgroups in EMPOWER-Lung 1. Annals of Oncology, 33, S1573. | en_US |
dc.identifier.doi | 10.1016/j.annonc.2022.10.372 | en_US |
dc.identifier.endpage | S1573 | en_US |
dc.identifier.issn | 0923-7534 | en_US |
dc.identifier.issn | 1569-8041 | en_US |
dc.identifier.issue | 9 | en_US |
dc.identifier.startpage | S1573 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1016/j.annonc.2022.10.372 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/3922 | |
dc.identifier.volume | 38 | en_US |
dc.identifier.wos | WOS:000897943700339 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.institutionauthor | Kılıçkap, Saadettin | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Annals of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Patient-reported outcomes with cemiplimab versus chemotherapy in advanced non-small cell lung cancer (aNSCLC): geographic region subgroups in EMPOWER-Lung 1 | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 1-s2.0-S092375342204563X-main (1).pdf
- Boyut:
- 101.72 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: